Technology & Diagnostics

At EDEN, advanced technology begins with advanced diagnostics. We combine digital skin analysis, medical ultrasound, and carefully selected energy-based technologies to make aesthetic treatment more precise, personalized, and clinically informed.

Our diagnostic approach includes VISIA digital skin analysis, allowing us to assess multiple characteristics of the skin, identify concerns that may not be fully visible to the naked eye, document baseline skin condition, and objectively monitor changes over time. Our diagnostic capabilities continue to expand as we integrate new technologies into our clinical assessment process.

Medical ultrasound provides another level of information in selected cases, allowing our doctors to visualize underlying facial structures and previously injected material and to perform ultrasound-guided injections when clinically appropriate.

For facial rejuvenation and skin tightening, we use the Jeisys ULTRAcel platform, combining microneedle RF, HIFU focused ultrasound, and non-invasive Grid RF. Different modalities can be selected according to skin quality, tissue depth, degree of laxity, facial anatomy, and individual treatment goals.

Our technology portfolio also includes DEKA CoolPeel fractional CO₂ laser for controlled skin resurfacing and rejuvenation, and ATTIVA radiofrequency technology for targeted tissue tightening and collagen remodeling.

For laser and light-based treatments, EDEN uses the DEKA Alexandrite laser for laser hair removal and the XLase multi-technology platform, incorporating CPL (Calibrated Pulsed Light), Nd, and Q-Switched laser technologies for selected pigmentation, photodamage, vascular concerns, spider veins, uneven skin tone, and other appropriate indications.

These technologies are not used in isolation. Depending on the individual assessment, our doctors may combine RF microneedling, HIFU, Grid RF, fractional CO₂ laser resurfacing, skin tightening, pigmentation and vascular treatments, injectable procedures, and other modalities within a personalized treatment strategy.

We do not select technology simply because it is new or popular. We select it according to its clinical purpose, safety profile, and place within the patient's overall treatment plan.

The technology may be advanced. The clinical decision behind using it must be even more advanced.